Global Blood Coagulation Analyzer Market 2016-2020

Overview of the global blood coagulation analyzer market

Technavio’s market research analyst predicts that the global blood coagulation analyzer market will grow at a CAGR of more than 8% by 2020.  Blood coagulation analyzers are used to estimate the composition of blood after blood tests. The coagulation analyzers available these days are fully automated with several advanced features to perform various functions such as primary tube sampling, cap piercing, automatic rerun, and dilution. They can perform sophisticated coagulation, chromogenic, and immunologic assays by using a smaller sample and reagent volume of the blood. Factors such as portability, accuracy, connectivity, timely results, and ease-of-use have increased the usage of these devices and have created ample opportunities for the vendors to come up with more effective and efficient solutions over the next four years.

An interesting trend gaining traction in the market is the growing use of anticoagulant therapy. Anticoagulant therapy is used for the treatment of clotting disorders occurring due to abnormal blood clots. It is used for treating atrial fibrillation, artificial heart valve, DVT, PE, stroke, and heart attack. Several governing bodies, including Anticoagulation Europe and Anticoagulation Self-monitoring Alliance, have taken initiatives to create awareness of the ill-effects of anticoagulant therapy. This increase in the awareness will increase the demand for coagulation testing, which in turn will propel the market in the coming years.

Segmentation by product type and analysis of the blood coagulation analyzer market

• Instruments
• Consumables